ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Blood count abnormal | 13.01.07.001 | - | - | Not Available |
Oral mucosa erosion | 07.05.06.009 | - | - | Not Available |
Malignant transformation | 16.16.01.013 | 0.000278% | | Not Available |
Ulcerative keratitis | 06.04.02.004; 10.02.01.021 | 0.000533% | | |
Bone marrow failure | 01.03.03.005 | - | - | |
Treatment failure | 08.06.01.017 | 0.000764% | | Not Available |
Liver injury | 12.01.02.003; 09.01.07.022 | - | - | Not Available |
Organising pneumonia | 22.01.02.008 | 0.000533% | | Not Available |
Oral disorder | 07.05.01.005 | 0.000799% | | Not Available |
Oropharyngeal pain | 22.02.05.022; 07.05.05.004 | - | - | |
Acute kidney injury | 20.01.03.016 | 0.007992% | | |
Drug-induced liver injury | 12.03.01.044; 09.01.07.023 | 0.001332% | | Not Available |
Pneumocystis jirovecii pneumonia | 22.07.08.009; 11.03.07.005 | 0.000208% | | Not Available |
Candida infection | 11.03.03.021 | 0.000799% | | |
Faeces soft | 07.01.03.008 | 0.000533% | | Not Available |
Multiple organ dysfunction syndrome | 08.01.03.057 | - | - | |
Liver function test increased | 13.03.01.044 | - | - | Not Available |
Abnormal loss of weight | 14.03.02.019 | 0.000533% | | Not Available |
Brain neoplasm malignant | 17.20.04.002; 16.30.04.002 | 0.000208% | | Not Available |
Carcinoembryonic antigen increased | 13.22.01.009 | 0.000799% | | Not Available |
Lung adenocarcinoma | 22.08.01.007; 16.19.01.002 | 0.000417% | | Not Available |
Lymphadenopathy mediastinal | 22.09.03.006; 01.09.01.025 | 0.000278% | | Not Available |
Malignant ascites | 16.32.03.013; 07.07.01.004 | 0.000208% | | Not Available |
Malignant pleural effusion | 22.05.04.001; 16.32.03.014 | 0.000556% | | Not Available |
Metastases to adrenals | 16.22.02.012; 05.01.04.007 | 0.000533% | | Not Available |
Metastases to bone | 16.22.02.005; 15.09.03.006 | 0.002154% | | Not Available |
Metastases to lymph nodes | 01.09.01.015; 16.22.02.006 | 0.000347% | | Not Available |
Metastases to pleura | 22.05.04.002; 16.22.02.022 | 0.000278% | | Not Available |
Recurrent cancer | 16.16.01.015 | 0.001066% | | Not Available |
Small cell carcinoma | 16.16.01.017 | 0.000417% | | Not Available |